Esther Sanfeliu

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

Francesco Schettini, Núria Chic, Fara Brasó‐Maristany et al. · npj Breast Cancer · 2021 · 691 citations · Full text

Medicine, Cancer Biology, Oncology +10

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Olga Martínez‐Sáez, Núria Chic, Tomás Pascual et al. · Breast Cancer Research · 2020 · 376 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 289 citations · Full text

Medicine, Oncology, Surgery +11

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

James Glasbey, Dmitri Nepogodiev, Joana Simões et al. · Journal of Clinical Oncology · 2020 · 222 citations · Full text

Medicine, Oncology, Surgery +11

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer

Aleix Prat, Valentina Guarneri, Tomás Pascual et al. · EBioMedicine · 2022 · 145 citations · Full text

Medicine, Bioinformatics, Oncology +17